Cardiac surgery and hematologic malignancies: A retrospective single-center analysis of 56 consecutive patients

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 1, 2011, Pages 173-178

  Sommer, Sebastian Patrick ^a   Lange, Volkmar ^a   Yildirim, Cagatay ^a   Schimmer, Christoph ^a   Aleksic, Ivan ^a   Wagner, Christoph ^a   Schuster, Christoph ^a   Leyh, Rainer G ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Cardiac surgery; Complication management; Leukemia

Indexed keywords

ALBUMIN; ANAGRELIDE; ASPARAGINASE; BILIRUBIN; CHOLINESTERASE; CREATININE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; HYDROXYUREA; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; RITUXIMAB; UREA; VINCRISTINE;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOCYTIC LEUKEMIA; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CHEMOTHERAPY; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; ERYTHROCYTE COUNT; HEART INFARCTION; HEART SURGERY; HEART VALVE SURGERY; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; INFECTIOUS COMPLICATION; INTERNATIONAL NORMALIZED RATIO; IRRADIATION; KIDNEY FAILURE; LUNG DISEASE; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR HEMOGLOBIN; MONOCLONAL IMMUNOGLOBULINEMIA; MORTALITY; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPTICEMIA; STROKE; SURVIVAL; UREA BLOOD LEVEL; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA, GENERAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; EPIDEMIOLOGIC METHODS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SURGICAL WOUND INFECTION;

EID: 79957974644     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.10.031     Document Type: Article

References (16)

1. Xie Y., Davies S.M., Xiang Y., Robison L.L., Ross J.A. Trends in leukemia incidence and survival in the United States (1973-1998). Cancer 2003, 97:2229-2235.
2. Arsenian M.A. Cardiovascular sequelae of therapeutic thoracic radiation. Prog Cardiovasc Dis 1991, 33:299-311.
3. Vlachaki M.T., Ha C.S., Hagemeister F.B., Fuller L.M., Rodriguez M.A., Besa P.C., Hess M.A., Brown B., Cabanillas F., Cox J.D. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies. Int J Radiat Oncol Biol Phys 1997, 39:609-616.
4. Kwaan H.C., Wang J. Hyperviscosity in polycythemia vera and other red cell abnormalities. Semin Thromb Hemost 2003, 29:451-458.
5. Mazzucato M., De Marco L., De Angelis V., De Roia D., Bizzaro N., Casonato A. Platelet membrane abnormalities in myeloproliferative disorders: decrease in glycoproteins Ib and IIb/IIIa complex is associated with deficient receptor function. Br J Haematol 1989, 73:369-374.
6. Villmow T., Kemkes-Matthes B., Matzdorff A.C. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb Res 2002, 108:139-145.
7. Wehmeier A., Scharf R.E., Fricke S., Schneider W. Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease. Haemostasis 1989, 19:251-259.
8. Negaard H.F., Iversen P.O., Ostenstad B., Mowinckel M.C., Sandset P.M. Increased acquired activated protein C resistance in unselected patients with hematological malignancies. J Thromb Haemost 2008, 6:1482-1487.
9. Hasselbalch H. Idiopathic myelofibrosis: a clinical study of 80 patients. Am J Hematol 1990, 34:291-300.
10. Wadhwa P.D., Morrison V.A. Infectious complications of chronic lymphocytic leukemia. Semin Oncol 2006, 33:240-249.
11. Christiansen S., Schmid C., Loher A., Scheld H.H. Impact of malignant hematological disorders on cardiac surgery. Cardiovasc Surg 2000, 8:149-152.
12. Samuels L.E., Kaufman M.S., Morris R.J., Styler M., Brockman S.K. Open heart surgery in patients with chronic lymphocytic leukemia. Leuk Res 1999, 23:71-75.
13. Ghosh P., Carroll I., Kanhere A., Ng B., Larbalestier R., Edwards M. Cardiac operations in patients with low-grade small lymphocytic malignancies. J Thorac Cardiovasc Surg 1999, 118:1033-1037.
14. Finck S.J., Cockerill K.J., Jeter J.E., Orszulak T.A. Coronary artery bypass grafting in patients with chronic lymphocytic leukemia. Ann Thorac Surg 1993, 55:1192-1196.
15. Potapov E.V., Zurbrugg H.R., Herzke C., Srock S., Riess H., Sodian R., Hubler S., Hetzer R. Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study. Ann Thorac Surg 2002, 74:384-389.
16. Al-Anazi K.A., Al-Jasser A.M., Evans D.A.P., Daff N.A. Outcome of surgery in patients with hematological malignancies: a 12-year retrospective analysis. Asia-Pacific J Clin Oncol 2006, 2:91-97.